Analyzing Beauty Health (NASDAQ:SKIN) & Ryman Healthcare (OTCMKTS:RYHTY)

Beauty Health (NASDAQ:SKIN) and Ryman Healthcare (OTCMKTS:RYHTY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.

Risk & Volatility

Beauty Health has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Ryman Healthcare has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500.

Insider & Institutional Ownership

93.3% of Beauty Health shares are held by institutional investors. 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Beauty Health and Ryman Healthcare”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$334.30 million	0.43	-$29.10 million	($0.22)	-5.14
Ryman Healthcare	$451.64 million	N/A	-$259.39 million	N/A	N/A

Beauty Health has higher earnings, but lower revenue than Ryman Healthcare.

Analyst Recommendations

This is a breakdown of recent recommendations for Beauty Health and Ryman Healthcare, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	2	4	1	0	1.86
Ryman Healthcare	0	0	0	0	0.00

Beauty Health presently has a consensus target price of $2.40, suggesting a potential upside of 112.39%. Given Beauty Health’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Beauty Health is more favorable than Ryman Healthcare.

Profitability

This table compares Beauty Health and Ryman Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Beauty Health	-3.87%	-19.70%	-1.97%
Ryman Healthcare	N/A	N/A	N/A

Summary

Beauty Health beats Ryman Healthcare on 7 of the 11 factors compared between the two stocks.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

About Ryman Healthcare

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hair salons, library, dining area, bar, lounges, croquet laws, shops, and movie theatre facilities. The company owns and operates retirement village units and care units. The company was founded in 1984 and is based in Christchurch, New Zealand.